Tamara Hampden 's Entries

1 blog
  • 15 Aug 2018
    Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning difficult to have these hurt by the drug the compensation they are entitled to.Although bleeding is a common complication connected with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, individuals could be at danger for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.In case you or a loved one particular suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For more details, get in touch with us right now to possess your case reviewed, totally free xarelto for one year of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Furthermore, they are searching for punitive damages, that are generally awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for far more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    67 Posted by Tamara Hampden
  • Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning difficult to have these hurt by the drug the compensation they are entitled to.Although bleeding is a common complication connected with anticoagulants, it has been alleged that Xarelto is more unsafe than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, individuals could be at danger for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.In case you or a loved one particular suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For more details, get in touch with us right now to possess your case reviewed, totally free xarelto for one year of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in circumstances of death, funeral costs. Furthermore, they are searching for punitive damages, that are generally awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a safe anticoagulant option.Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for far more data on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    Aug 15, 2018 67